FINANCIALS

RXRX Recursion Pharmaceuticals Inc 1601830

Income Statement
Revenue	rxrx-20241231	58,839,000
Net Income	rxrx-20241231	-463,661,000
Profit Margin		-788.02%

Balance Sheet
Current Assets	714,269,000
Assets	1,448,598,000
Current Liabilities	187,472,000
Liabilities	413,816,000
Equity	1,034,782,000
Shares Out	275,070,000

Cash Flow Statement
Operating Cash Flow	-359,174,000
Investing Cash Flow	260,059,000

Market Analysis
Market Cap	1,928,815,890
Price	6.55
BVPS	3.76
PB	1.75
EPS	-1.63
PS	8.20
FCF	-99,115,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view RXRX documents filed with the SEC.

RXRX Filings Clear

View A List of Tickers